Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared a post on X:
“Should we sequence ADCs?
Getting ready for a fierce debate at next week’s Breast Cancer Focus Meeting in Boston, chaired by Sara Tolaney and Virginia Kaklamani.
Challenging me, the undefeated champion Laura Huppert, supporting the NO SEQUENCING position.
Let’s get ready to rumble!”
Learn more about ADCs in cancer on OncoDaily.